Low reduction of prostate volume is a significant predictor of prostate cancer at subsequent biopsy in patients with dutasteride: A retrospective study

Appropriate decision of prostate biopsy in men with 5α‐reductase inhibitor (5AR inhibitor) is still unclear to avoid unnecessary biopsy. We retrospectively investigated patients with initial PSA 4.0 ng/ml or more and underwent subsequent prostate biopsy following dutasteride treatment. From Septembe...

Descripción completa

Detalles Bibliográficos
Autores principales: Obinata, Daisuke, Suzuki, Shugo, Yamanaka, Yataro, Yoshizawa, Tsuyoshi, Mochida, Junichi, Yamaguchi, Kenya, Takahashi, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757197/
https://www.ncbi.nlm.nih.gov/pubmed/32816374
http://dx.doi.org/10.1111/and.13810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757197/
https://www.ncbi.nlm.nih.gov/pubmed/32816374
http://dx.doi.org/10.1111/and.13810

Ejemplares similares